Effects of Reproductive Hormones on Experimental Vaginal Candidiasis
- 1 February 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (2) , 651-657
- https://doi.org/10.1128/iai.68.2.651-657.2000
Abstract
Vulvovaginal candidiasis (VVC) is an opportunistic mucosal infection caused by Candida albicans that affects large numbers of otherwise healthy women of childbearing age. Acute episodes of VVC often occur during pregnancy and during the luteal phase of the menstrual cycle, when levels of progesterone and estrogen are elevated. Although estrogen-dependent experimental rodent models of C. albicans vaginal infection are used for many applications, the role of reproductive hormones and/or their limits in the acquisition of vaginal candidiasis remain unclear. This study examined the effects of estrogen and progesterone on several aspects of an experimental infection together with relative cell-mediated immune responses. Results showed that while decreasing estrogen concentrations eventually influenced infection-induced vaginal titers of C. albicansand rates of infection in inoculated animals, the experimental infection could not be achieved in mice treated with various concentrations of progesterone alone. Furthermore, progesterone had no effect on (i) the induction and persistence of the infection in the presence of estrogen, (ii) delayed-type hypersensitivity in primary-infected mice, or (iii) the partial protection from a secondary vaginal infection under pseudoestrus conditions. Other results with estrogen showed that a persistent infection could be established with a wide range of C. albicans inocula under supraphysiologic and near-physiologic (at estrus) concentrations of estrogen and that vaginal fungus titers or rates of infection were similar if pseudoestrus was initiated several days before or after inoculation. However, the pseudoestrus state had to be maintained for the infection to persist. Finally, estrogen was found to reduce the ability of vaginal epithelial cells to inhibit the growth of C. albicans. These results suggest that estrogen, but not progesterone, is an important factor in hormone-associated susceptibility to C. albicans vaginitis.Keywords
This publication has 54 references indexed in Scilit:
- Differential Susceptibility of Two Species of Macaques to Experimental Vaginal CandidiasisThe Journal of Infectious Diseases, 1999
- Biological Role of Th Cell Subsets in Candidiasis (Part 1 of 2)Published by S. Karger AG ,1996
- Pathogenesis and Treatment of Recurrent Vulvovaginal CandidiasisClinical Infectious Diseases, 1992
- Immunologic Factors Influencing Susceptibility to Recurrent Candidal VaginitisClinical Obstetrics and Gynecology, 1991
- Regulation of the immune response to Candida albicans monocytes and progesteroneAmerican Journal of Obstetrics and Gynecology, 1991
- Candida albicans: Cellular immune system interactions during different stages of the menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1989
- Pathogenesis and Epidemiology of Vulvovaginal CandidiasisAnnals of the New York Academy of Sciences, 1988
- A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growthJournal of Immunological Methods, 1986
- Evaluation of vaginal antifungal formulations in vivoPublished by Oxford University Press (OUP) ,1979
- Experimental Vaginal Candidiasis in Mice; Its Implications for Superficial Candidiasis in Humans**From the Department of Pediatrics, Maimonides Hospital of Brooklyn, New York and the Dept. of Dermatology, New York University, Postgraduate Medical School, New York, N. Y.This work was supported by United States Public Health Service Grant E-1751, and by grants from the Squibb Institute for Medical Research and from the Jewish Philanthropic League of Brooklyn, New York.Journal of Investigative Dermatology, 1960